FUNDING OPPORTUNITIES Last Updated 09.05.06
  GRANT MAKING ORGANISATIONS    CURRENT GRANT OPPORTUNITIES
   

GRANT MAKING    
ORGANISATIONS    

 
  Alcohol Education and Rehabilitation Foundation (AER Foundation)- The AER Foundation’s primary aim is to encourage responsible consumption of alcohol and emphasise the dangers of licit substance misuse. They do so by funding organisations and individuals that are directly in touch with these issues in their communities, helping their programs to have better outcomes.
   
  Australian Associated Brewers Inc.- funds independent peer reviewed medical and epidemiological research into alcohol and health, through the Australian Brewers' Foundation.
   
  Australian Research Council (ARC) - ARC funds research and researchers under the National Competitive Grants Program (NCGP). These programs are grouped into Discovery, Linkage, and Centres & Networks.
   
 

Australian Rotary Health Research Fund - supports research that will improve community health, facilitates communication between participants, and preferably has an outcome that can be used by community groups. The Ian Scott Fellowship--recent graduates looking to build a career in the area of mental illness research, and the Mental Illness research grant--individuals or research teams in clinical or public health fields for support of research projects in mental illness.
are targeted at mental health research, but could be useful to those studying co-morbid populations.
   
  Brain Foundation (Australia) - supports research projects in the clinical neurosciences.  Grants are to be used for equipment, support personnel, or other assistance necessary for a specific project.  The Foundation does not encourage applications that imply an ongoing commitment beyond a single year.  It will consider making a contribution to the cost of expensive items of equipment provided that the remaining costs can be met from other sources within a stipulated period.
   
  The Cooperative Research Centres (CRC) Programme - established to bring together researchers and those who benefit from the research. The program emphasises the importance of collaborative arrangements to maximise the benefits of research through an enhanced process of utilisation, commercialisation, and technology transfer.
   
  Community of Science (COS) - a comprehensive source of grant opportunities. Updated regularly.
   
  European Union FP6 research funding - The European Framework Programme is the main EU funding body for research.
   
  Fogerty International Center (FIC) - serves as the centre for NIH international activities. FIC fosters research partnerships between U.S. scientists and foreign counterparts through international research grants.
   
 

Howard Hughes Medical Research Institute - International Research Scholars--five-year grants support promising non-U.S. scientists working outside the United States. HMRI is seeking scientists who are making a significant contribution to the understanding of basic biological processes or disease mechanisms, but their careers are still developing.
 

 
 

Human Frontier Science Program - supports basic research focused on complex mechanisms of living organisms. The fields supported range from molecular and cellular approaches to biological functions to systems and cognitive neuroscience. Particular emphasis is placed on bringing scientists from fields such as physics, mathematics, chemistry, computer science, bioinformatics, nanoscience, and engineering together with biologists to open up new approaches to understanding complex biological systems.Scentists from all countries can participate, but the principal applicant must be from a member country. The Principal Applicant of a research grant must be from one of the member countries Australia is a member country. Applicants for research grants must first submit a letter of intent online. The 2007 call for Letters of Intent is now open (registration deadline March 20th 2006, submission deadline March 30th 2006).

   
  Ian Potter - has traditionally shown strong support for medical research. They normally do not support projects, salaries, or equipment that would be funded by NH&MRC or the ARC, nor do they support purposes where institutional operating funds would be more appropriate, or projects or scholarships that would be awarded by the grantseeker to a third party.
The Foundation is unlikely to fund research projects for which there would be a reasonable prospect of attracting commercial funding. Closing dates for 2006 applications are 1 February, ,1 May, 1 August, 2 November.
   
  James S MacDonnell Foundation - The 21st Century Science Initiative funds research in three areas: Bridging Brain, Mind, and Behavior, Studying Complex Systems, and Brain Cancer Research..The Bridging Brain, Mind, and Behavior Program supports interdisciplinary research linking brain function, cognition, and behaviour.
The Foundation funds two types of grants: 21st Century Research Awards--A maximum of $450,000 total costs can be requested for 3-6 years. The applicant can apply the grant funds towards any research-based expense, including travel, equipment, and supplies. Funds can be used to support collaborative projects.
Collaborative Activity Awards—are meant to initiate interdisciplinary discussions on problems or issues, to help launch interdisciplinary research networks, or to fund communities of researchers/practitioners dedicated to developing new methods, tools, and applications of basic research to applied problems. Collaborative funds may be used to support the organisation of study panels, research networks, or other ways of bringing investigators from different institutions and possibly different disciplines together in the service of important questions.
Applicants should submit a letter of inquiry not to exceed 1000 words in length. There are no application deadlines.
   
  National Health and Medical Research Council (NHMRC) - applications are accepted only from teams of individuals whose research will be conducted under the auspices of a recognised institution.
   
  National Institutes of Health (NIH) -research grant policies, guidelines and funding opportunities
   
  The NIH Roadmap - a series of progressive initiatives that seek to transform the US biomedical research capabilities and accelerate the advancement of research discoveries from the bench to the bedside. The Roadmap is composed of three overarching themes: new pathways to discovery, research teams of the future, and re-engineering the clinical research enterprise. All three of these broad initiatives have current and future funding opportunities associated with them, which NIDA grantees can apply.
   
  National Institute on Alcohol Abuse and Alcoholism - one of the National Institutes of Health, NIAAA was established to address the prevention and treatment of alcohol abuse and alcoholism and rehabilitation, and funds research in these areas.
   
  National Institute on Drug Abuse - one of the National Institutes of Health, NIDA supports research in drug abuse and addiction.


CURRENT GRANT    
OPPORTUNITIES    
 

The Clive and Vera Ramaciotti Foundations--Applications are invited for Establishment grants, short-term support for a scientist/clinical investigator recently appointed to an academic or hospital position with a minimum of three years tenure, and Major Equipment grants, for a contribution of $30,000 for or towards the purchase of a single item of equipment costing $30,000 or more. Applications must be lodged via the web site no later than 30 June 2005. Late applications will not be considered.
  NIH  
  • Building Translational Research in Integrative Behavioral Science (R21)   Expiration date: 2 May 2009 unless reissued. This Funding Opportunity Announcement (FOA) is intended to encourage the development of translational research partnerships between scientists who study basic behavioral processes and those who study the etiology, diagnosis, treatment, and prevention of mental and behavioral disorders (including alcohol and drug use disorders) and the delivery of services to those suffering from those disorders. RO1, R24.
     
  • NIH Exploratory/Developmental Research Grant Program   Expiration date: 2 May 2009 unless reissued. The Exploratory/Developmental Grant (R21) mechanism is intended to encourage exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research.
     
  • Community Participation in Reseach Letters of Intent Receipt Date(s): April 17 2007. Expiration Date: May 18, 2007 The goal of this FOA is to support research on health promotion, disease prevention, and health disparities that is jointly conducted by communities and researchers. This FOA invites NIH exploratory/developmental grant (R21) award mechanisms.
     
  • Mechanism for Time-Sensitive Research Opportunities Expiration/Closing Date: June 10, 2009 This Funding Opportunity Announcement (FOA) is intended to support mental health and/or substance abuse services research, as well as broader-based alcohol or drug abuse research in rapidly evolving areas (e.g., changes in service systems, health care financing, policy, etc) where opportunities for empirical study are, by their very natures, only available through expedited award of support.
     
  NIAAA  
  • NIAAA Research Program Announcements
     
  • Mechanisms of Alcohol-Induced Tissue Injury   Expiration date: 2 March 2008.
NIAAA invites grant applications to study the cellular and molecular mechanisms of tissue injury caused by ethanol consumption. The NIAAA is especially interested in comparative and interactive (or integrative) research that elucidates mechanisms of injury common to many body and organ systems, with the eventual goal of identifying early markers of ethanol induced pathology and developing therapeutic strategies to serve multiple alcohol-related disorders.
     
  • Finding Genes for Alcohol-Related Behaviors and Risk for Alcoholism   Expiration date: 1 August 2006, unless reissued. Soliciting research proposals to identify and characterize genes that contribute to individual susceptibility to alcoholism and alcohol-related behaviors. This PA encourages multidisciplinary studies using advanced genetic and genomics technologies to find and characterize candidate genes in humans and animal models.
  NIDA  
  • Basic and Translational Research in Emotion   Expiration date: 2 March 2009 The purpose of this Funding Opportunity Announcement (FOA) is to invite grant applications to expand basic and translational research on the processes and mechanisms involved in the experience, expression and regulation of emotion.
     
  • Developmental Psychopharmacology   Expiration date: 2 March 2009 The purpose of this Funding Opportunity Announcement (FOA) is to invite grant applications to expand basic and translational research on the processes and mechanisms involved in the experience, expression and regulation of emotion.
     
  • Women, Sex/Gender Differences and Drug Abuse (R21)  Expiration date: 30 June 2006 The purpose of this Funding Opportunity Announcement is to encourage sex/gender-based drug abuse research that focuses on the mechanisms, origins, and consequences of drug abuse, as well as prevention and treatment interventions and services. It also encourages the study of female-specific issues in all areas of drug abuse. (R03) to encourage sex/gender-based drug abuse research that focuses on the mechanisms, origins, and consequences of drug abuse, as well as prevention and treatment interventions and services. It also encourages the study of female-specific issues in all areas of drug abuse.
     
  • Epidemiology Of Drug Abuse (R21)  Expiration date: 2 September 2007This Funding Opportunity Announcement is intended to support exploratory/ developmental research projects that address 1) drug use patterns and trends within and across populations; (2) interplay of social interactions, social environment, structural context with individual behavioral characteristics and genetic vulnerability; (3) the phenotypic heterogeneity of drug abuse; (4) causal mechanisms leading to onset, maintenance, and remittance of drug abuse, as well as protective mechanisms that reduce the risk of drug abuse; and (5) drug abuse over the life course.(R03) to fund small research projects.
     
  • Inhalant Abuse: Supporting Broad-Based Research Approaches   Expiration date: 2 July 2008 The goal of this funding opportunity announcement is to encourage research on all aspects of inhalant abuse (i.e., epidemiology; prevention, treatment and service delivery; antecedents, consequences and neurobiological mechanisms).
     
  • Drug Abuse Prevention Intervention Research (R21)  Expiration date: 2 September 2008 The goals of this Funding Opportunity Announcement are to encourage exploratory/developmental research projects of cognitive, behavioral, and social processes as they relate to: 1) the development of novel drug abuse prevention approaches; 2) the efficacy and effectiveness of newly developed and/or modified prevention programs; 3) the processes associated with the selection, adoption, adaptation, implementation, sustainability, and financing of empirically validated interventions; and 4) methodologies appropriate for studying complex aspects of prevention science. (R03) to encourage pilot/feasibility research
     
  • Cutting-Edge Basic Research Awards (CEBRA) Expiration Date: 2 May 2009, unless reissued. The NIDA Cutting-Edge Basic Research Award is designed to foster highly innovative or conceptually creative research related to drug abuse and addiction and how to prevent and treat them, and to support research that is high-risk and potentially high-impact that is underrepresented or not included in NIDA's current portfolio.
     
  • Gene Discovery for Complex Neurological and Neurobehavioral DisordersExpiration Date: 2 July 2006 . The goal of this Funding Opportunity Announcement (FOA) is to promote the identification of susceptibility genes for complex neurological and neurobehavioral disorders. 
     
  • International Research Collaboration on Drug Addiction Expiration Date: 3 January 2009. This Program Announcement (PA) solicits collaborative research proposals on drug abuse and addiction that take advantage of special opportunities that exist outside the United States. Special opportunities include access to unusual talent, resources, populations, or environmental conditions in other countries that will speed scientific discovery.
     
  • Drug Abuse Prevention Intervention Research
 Expiration Date: 2 September 2008 The goals of this program announcement are to encourage investigations of cognitive, behavioral, and social processes as they relate to: 1) the development of novel drug abuse prevention approaches; 2) the efficacy and effectiveness of newly developed and/or modified prevention programs; 3) the processes associated with the selection, adoption, adaptation, implementation, sustainability, and financing of empirically validated interventions; and 4) methodologies appropriate for studying complex aspects of prevention science.
     
  • Inhalant Abuse: Supporting Broad-Based Research Approaches
Expiration Date: 2 July 2008. The goal of this program announcement is to encourage research on all aspects of inhalant abuse (i.e., epidemiology; prevention, treatment and service delivery; antecedents, consequences and neurobiological mechanisms).
   
  • Collaborative Multisite Research in Addiction (COMRAD) Program Announcement Expiration date: 2 March 2008.
The National Institute on Drug Abuse (NIDA) seeks to increase the collaboration of investigators at two or more sites in order to address critical issues in the epidemiology, services, and prevention of substance abuse and related disorders that require sample sizes greater than a single site can reasonably attain.
     
  • Research on Mind-Body Interactions and Health Expiration date: 3 January 2008.
"Mind-body interactions and health" refers to the relationships among cognitions, emotions, personality, social relationships, and health. A central goal of this program is to encourage interdisciplinary collaboration and innovation towards understanding the processes underlying mind-body interactions and health as well as towards the application of such basic knowledge to interventions and clinical practice in the promotion of health and the prevention or treatment of disease and disabilities.
     
  • MDMA: Research areas needing more emphasis   Expiration date: 2 January 2008, unless reissued.The purpose of this PA is to provide an optimally comprehensive, strategic, and balanced MDMA (3,4-methylenedioxymethamphetamine) research program, given the upsurge in MDMA abuse worldwide, including its abuse outside the rave scene. Although researchers have made great strides in characterizing MDMA’s neural mechanisms and neurotoxicity, it is necessary now to focus on specific areas of MDMA research, across all research disciplines, urgently needing our attention.
     
  •

Characterization, Behavior And Plasticity Of Pluripotent Stem Cells  Expiration date: 2 July 2007Applications are invited for studies on the characterization, behavior and plasticity of human and non-human stem cells, regulation of their replication, differentiation, integration and function in the nervous system, and the identification and characterization of normal and tumor stem cells.

     
  • Epidemiology Of Drug Abuse  Expiration date: 2 September 2007, unless reissued.
The major goal of this PA is to stimulate innovative investigations that enhance our understanding of: (1) drug use patterns and trends within and across populations; (2) interplay of social interactions, social environment, structural context with individual behavioral characteristics and genetic vulnerability; (3) the phenotypic heterogeneity of drug abuse; (4) causal mechanisms leading to onset, maintenance, and remittance of drug abuse, as well as protective mechanisms that reduce the risk of drug abuse; and (5) drug abuse over the life course, including developmental processes that influence drug use trajectories and behavioral, health, and social consequences of drug abuse.
     
  • Pharmacotherapy for Comorbid Alcohol and Drug Use Disorders   Expiration date: 30 January 2007, unless reissued. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Institute on Drug Abuse (NIDA) are seeking research grant applications on pharmacological treatment for patients with alcohol use disorder (AUD) and a comorbid substance use disorder (SUD).
     
  • Gene Discovery for Complex Neurological and Neurobehavioral Disorders Expiration date: 1 June 2006, unless reissued. The goal of this Program Announcement is to promote the identification of susceptibility genes for complex neurological and neurobehavioral disorders. For this PA, complex disorders are defined as those caused by the interaction of multiple genes, or by a combination of genetic and environmental risk factors.
     
  • Basic and Translational Research in Emotion  Expiration date: September 2006, unless reissued. Under this PA, the National Institute of Mental Health, National Institute on Aging, National Institute on Alcohol Abuse and Alcoholism, National Cancer Institute, National Institute of Child Health and Human Development, National Institute on Drug Abuse, and the National Institute of Neurological Disorders and Stroke invite research grant applications to expand basic and translational research on the processes and mechanisms involved in the experience and expression of emotion.
     
  • Molecular Genetics of Drug Addiction Vulnerability  Expiration date: 30 July 2006, unless reissued. This PA seeks investigator-initiated applications for research projects that identify chromosomal loci and genetic variation in genes and haplotypes that are associated with increased vulnerability to addiction or dependence on stimulants (e.g., cocaine and amphetamine), narcotics (e.g., opiates), nicotine, benzodiazepines, barbiturates, cannabis, hallucinogens, and/or multiple drugs of abuse in human beings. Much diagnostic effort has been focused on DSM criteria; we are additionally interested in applications that will examine intermediate phenotypes (endophenotypes) to better assess the molecular genetics of drug addiction and drug addiction vulnerability. Thus, applications examining the genetics of addiction vulnerability to both illicit and legal drugs of abuse are relevant to this PA.